Eton Pharmaceuticals (ETON) Return on Sales [ROS] (2019 - 2026)
Eton Pharmaceuticals (ETON) recorded Return on Sales [ROS] of 34.04% in Q2 2026, up 41.83 percentage points from -7.79% a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
On a TTM basis, Eton Pharmaceuticals' Return on Sales [ROS] came in at 12.39% as of Jun 30, 2026, up 13.78 percentage points year-over-year; for FY2025, it came in at -1.06%, up 5.60 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +69514.33 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -6.66% in FY2024 (-2.89 pp), -3.77% in FY2023 (+35.10 pp), -38.87% in FY2022 (-32.02 pp) and -6.85% in FY2021 (+69508.54 pp).
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q1 2021.
- On a year-over-year basis, Return on Sales [ROS] rose in six of the last seven quarters, with an average year-over-year change of +16.32 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 9808.93 percentage points in Q4 2021, against a drop of 278.86 percentage points in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Eton Pharmaceuticals | 1.95 Bn | 1.82 Bn | 44.30 Mn | 39.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 39.73% |
| Jun 30, 2026 | 34.04% |
| Mar 31, 2026 | 9.95% |
| Dec 31, 2025 | 11.58% |
| Sep 30, 2025 | -6.07% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -2.72% |
| Dec 31, 2024 | 5.40% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -10.04% |
| Dec 31, 2023 | -27.25% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | -47.78% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | -89.93% |
| Jun 30, 2022 | -18.21% |
| Mar 31, 2022 | -233.78% |
| Dec 31, 2021 | 21.57% |
API Access
Eton Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();